Study initiation: Staff of KHRC Trained on Mal073 study

(Kintampo, 15th June 2017) – PPD in collaboration with KHRC has been facilitating the smooth initiation of the Mal 073 study to be carried out in Kintampo. One such activity is the training of staff on the project.
Staff of the Kintampo Health Research Centre who are to work on the Mal073(Malaria 073) study have been undergoing training since the 5th of June 2017 for the smooth take off of the study.
The study is a Phase IIIb randomized, open, controlled, multi-center study to evaluate the immunogenicity and safety of the RTS,S/AS01E candidate malaria vaccine, when administered as primary vaccination with or without co-administration of measles, rubella and yellow fever vaccines followed by an RTS,S/AS01E booster vaccination to children living in sub-Saharan Africa.
The study which is being funded by GSK is a multi-site study involving Kintampo and Agogo areas in Ghana.
The study staff have been trained on the various SOPs, the Case Report forms (CRFs), Good Clinical Practice (GCP), and Lessons learned from Mal 055 as well as training on the protocol of the study. The training ended yesterday, 15th June 2017, with the study initiation training facilitated by staff from PPD (Linda and Daniel) and some staff from KHRC. The study is thus ready for a smooth start in the Kintampo area in the middle belt of Ghana.